HS387

HS387 · Zhejiang Hisun Pharmaceutical Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HS387, covering 2025-07-30 to 2025-07-30. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors [Phase 1]